
Alphatec Hlds (ATEC) Stock Forecast & Price Target
Alphatec Hlds (ATEC) Analyst Ratings
Bulls say
Alphatec Holdings is poised to see continued growth and sales in the future due to their innovative spinal surgery technologies and expanding surgeon base. While they did miss revenue expectations for the quarter, their strong margin performance and maintainment of their adjusted EBITDA outlook showcase their ability to drive meaningful operating leverage and improve gross margins. Additionally, the company has taken steps to address execution issues around their EOS franchise, which is expected to improve in the second half of the year. Overall, Alphatec Holdings remains a strong investment with potential for future success in the medical technology industry.
Bears say
Alphatec Holdings is facing challenges with its sales execution and missed hardware sales, leading to lower than expected revenue from its EOS imaging business. The company has taken steps to address these issues, but its revenue guidance has been lowered for the year. Despite this, management believes the company can maintain profitability. Risks to the target price include poor sales execution and competition in the spine market, as well as the potential for dilutive equity offerings or acquisitions. While the latest earnings report was below expectations, the underlying market for the company's products remains healthy and the pullback in the stock price may be overdone.
This aggregate rating is based on analysts' research of Alphatec Hlds and is not a guaranteed prediction by Public.com or investment advice.
Alphatec Hlds (ATEC) Analyst Forecast & Price Prediction
Start investing in Alphatec Hlds (ATEC)
Order type
Buy in
Order amount
Est. shares
0 shares